Niche products, superior execution boost earnings

Company
21 May 2024
5 Min read 
  • Zydus LifeSciences 4QFY24 results update
  •  Financials & Valuations for Y/E March FY24 FY25E FY26E
  •  Levers in place to improve business prospects over next 2-3 years
  •  ZYDUS delivered a better-than-expected 4QFY24 performance
  •  Efforts underway to enhance product portfolio across key markets
  •  Maintain Neutral on the stock
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority